Full name
"NOBEL BIOCARE POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"NOBEL BIOCARE POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JANA PAWŁA II 27, 00-867 WARSZAWA
TAX ID5261034928
Rate company:
"NOBEL BIOCARE POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5261034928
KRS0000028259
Share capital50,000.00 zł
address
UL. JANA PAWŁA II 27, 00-867 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5261034928
REGON
011212340
KRS
0000028259
Legal form
limited liability company
Register Address
UL. JANA PAWŁA II 27, 00-867 WARSZAWA
Date of registration in KRS
2001-07-17
Date of commencement of economic activity
2001-07-17
Act signature
WA.XIII NS-REJ.KRS/2748/25/358/ADE
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.74.Z - Retail sale of medical and orthopedic products
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
73.20.Z - Market research and public opinion polling
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
Payer VAT status
Active
Vat list bank account(s)
PL87 1880 0009 0000 0011 0244 7001 
PL17 1880 0009 0000 0011 0244 7000 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,5 | 0,4 | 0,5 | 20,2 |
EBITDA | 0,5 | 0,4 | 0,5 | 13,7 |
Short time liabilities | 2,3 | 5,1 | 5,6 | 9,6 |
Equity capital | 3 | 3,4 | 3,4 | -0,7 |
Operating profit (EBIT) | 0,5 | 0,4 | 0,4 | 10,2 |
Assets | 6,6 | 10,6 | 10,8 | 2 |
Net profit (loss) | 0,1 | 0,4 | -0 | -106,5 |
Cash | 1,1 | 4,2 | 2,3 | -44,1 |
Net income from sale | 14,8 | 18,4 | 21,9 | 19,2 |
Liabilities and provisions for liabilities | 3,6 | 7,1 | 7,4 | 3,3 |
Working assets | 6,4 | 10 | 10,1 | 0,8 |
Depreciation | 0 | 0 | 0 | 89 |
% | % | % | p.p. | |
Profitability of capital | 2,1 | 11,3 | -0,7 | -12 |
Equity capital to total assets | 45,9 | 32,4 | 31,5 | -0,9 |
Gross profit margin | 3,1 | 2,4 | 2,4 | 0 |
EBITDA Margin | 3,3 | 2,2 | 2,1 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 57 | 102 | 94 | -8 |
Current financial liquidity indicator | 1.7793285846710205 | 1.4066214561462402 | 1.3727562427520752 | 0 |
Net dept to EBITDA | -2.193392276763916 | -10.566758155822754 | -5.196413040161133 | 5,4 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Gama Sp. z o.o.
Ruda Śląska
Katarzyna Zielińska-Mika APTEKARZ
Nakło nad Notecią
Med Digital sp. z o.o.
Warszawa
CYTOGEN-POLSKA
ŁÓDŹ
Red Shirt Barber
Warszawa